Sun Pharma acquires Taro Pharmaceutical
Pharma & Medical ProductsSun Pharma to Acquire Remaining Taro Shares for $348 MillionSun Pharma to Acquire Remaining Taro Shares for $348 Million
The pharmaceutical company already owns about 78.5% stake in Taro.
Sign up for the Powder & Bulk Solids Weekly newsletter.